5 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... antimicrobial therapy ... for purulent meningitis ... condition #IDSA ... Antimicrobials #Empiric #Coverage
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... Treatment #management #meningitis ... #cryptococcus #
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... for Cryptococcal ... and Maintenance Therapy ... Meningoencephalitis #IDSA ... Treatment #management #meningitis
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... Treatment #management #meningitis ... #cryptococcus #
The algorithm below shows how pre-test probability could be combined with various criteria to determine which
A patient with average ... treatment would delay therapy ... than bacterial meningitis ... day's delay in therapy ... #Management #Meningitis